News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
173,786 Results
Type
Article (8128)
Company Profile (121)
Press Release (165537)
Section
Business (57523)
Career Advice (269)
Deals (9950)
Drug Delivery (19)
Drug Development (22517)
Employer Resources (22)
FDA (4177)
Job Trends (4576)
News (92145)
Policy (6553)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (2)
Academia (598)
Accelerated approval (10)
Adcomms (4)
Allergies (48)
Alliances (8760)
ALS (30)
Alzheimer's disease (482)
Antibody-drug conjugate (ADC) (75)
Approvals (4365)
Artificial intelligence (108)
Autoimmune disease (38)
Automation (13)
Bankruptcy (50)
Best Places to Work (3758)
BIOSECURE Act (5)
Biosimilars (44)
Biotechnology (73)
Bladder cancer (58)
Brain cancer (13)
Breast cancer (256)
Cancer (1535)
Cardiovascular disease (132)
Career advice (241)
Career pathing (5)
CAR-T (75)
CDC (6)
Cell therapy (205)
Cervical cancer (15)
Clinical research (20717)
Collaboration (335)
Compensation (187)
Complete response letters (12)
COVID-19 (683)
CRISPR (23)
C-suite (103)
Cystic fibrosis (35)
Data (2267)
Depression (31)
Diabetes (152)
Diagnostics (1765)
Digital health (13)
Diversity, equity & inclusion (7)
Drug discovery (57)
Drug pricing (29)
Drug shortages (6)
Duchenne muscular dystrophy (54)
Earnings (41939)
Editorial (13)
Employer branding (2)
Employer resources (22)
Events (26760)
Executive appointments (126)
FDA (5209)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (10)
Funding (271)
Gene editing (53)
Generative AI (7)
Gene therapy (174)
GLP-1 (288)
Government (1042)
Grass and pollen (3)
Guidances (310)
Healthcare (5412)
HIV (22)
Huntington's disease (18)
IgA nephropathy (39)
Immunology and inflammation (74)
Immuno-oncology (13)
Indications (35)
Infectious disease (755)
Inflammatory bowel disease (40)
Inflation Reduction Act (1)
Influenza (31)
Intellectual property (45)
Interviews (28)
IPO (6087)
IRA (6)
Job creations (1009)
Job search strategy (221)
JPM (14)
Kidney cancer (6)
Labor market (23)
Layoffs (142)
Leadership (4)
Legal (1126)
Liver cancer (19)
Longevity (3)
Lung cancer (245)
Lymphoma (149)
Machine learning (10)
Management (6)
Manufacturing (184)
MASH (50)
Medical device (3587)
Medtech (3599)
Mergers & acquisitions (4224)
Metabolic disorders (365)
Multiple sclerosis (59)
NASH (5)
Neurodegenerative disease (71)
Neuropsychiatric disorders (24)
Neuroscience (805)
NextGen: Class of 2026 (1621)
Non-profit (1100)
Now hiring (15)
Obesity (156)
Opinion (37)
Ovarian cancer (50)
Pain (55)
Pancreatic cancer (60)
Parkinson's disease (73)
Partnered (9)
Patents (95)
Patient recruitment (111)
Peanut (16)
People (7757)
Pharmaceutical (31)
Pharmacy benefit managers (7)
Phase 1 (5364)
Phase 2 (9015)
Phase 3 (7966)
Pipeline (2304)
Policy (35)
Postmarket research (741)
Preclinical (1661)
Press Release (21)
Prostate cancer (70)
Psychedelics (13)
Radiopharmaceuticals (47)
Rare diseases (244)
Real estate (1256)
Recruiting (11)
Regulatory (5485)
Reports (16)
Research institute (576)
Resumes & cover letters (26)
Rett syndrome (18)
RNA editing (5)
RSV (15)
Schizophrenia (53)
Series A (41)
Series B (28)
Service/supplier (2)
Sickle cell disease (30)
Special edition (8)
Spinal muscular atrophy (46)
Sponsored (11)
Startups (664)
Stomach cancer (5)
Supply chain (21)
Tariffs (20)
The Weekly (5)
Vaccines (248)
Venture capital (20)
Weight loss (106)
Women's health (23)
Worklife (3)
Date
Last 7 days (186)
Last 30 days (509)
Last 365 days (9180)
2026 (809)
2025 (9419)
2024 (10446)
2023 (11613)
2022 (14906)
2021 (15943)
2020 (14822)
2019 (12472)
2018 (9380)
2017 (8561)
2016 (7840)
2015 (9240)
2014 (6215)
2013 (4298)
2012 (4974)
2011 (5418)
2010 (4452)
Location
Africa (166)
Alabama (17)
Arizona (63)
Arkansas (1)
Asia (10210)
Australia (1811)
California (3374)
Canada (874)
China (292)
Colorado (135)
Connecticut (110)
Delaware (135)
Europe (24955)
Florida (478)
Georgia (115)
Hawaii (1)
Idaho (11)
Illinois (238)
India (15)
Indiana (168)
Iowa (6)
Japan (159)
Kansas (29)
Kentucky (11)
Louisiana (14)
Maine (14)
Maryland (422)
Massachusetts (2392)
Michigan (80)
Minnesota (224)
Mississippi (4)
Missouri (31)
Montana (15)
Nebraska (4)
Nevada (52)
New Hampshire (30)
New Jersey (1217)
New Mexico (4)
New York (901)
North Carolina (420)
Northern California (1677)
Ohio (83)
Oklahoma (8)
Oregon (8)
Pennsylvania (622)
Puerto Rico (1)
Rhode Island (16)
South America (306)
South Carolina (4)
South Dakota (1)
Southern California (1355)
Tennessee (33)
Texas (461)
United States (11960)
Utah (97)
Virginia (48)
Washington D.C. (19)
Washington State (273)
West Virginia (1)
Wisconsin (42)
173,786 Results for "40".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
BioSpace
Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit
The inaugural 40 Under 40 cohort includes CEOs, leaders who have founded or co-founded their company and executives from a range of disciplines. Winners’ accomplishments include shaping drug development, achieving key FDA milestones and launching a new field of study.
October 7, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Trailhead Biosystems Expands Financing to $40 Million
January 13, 2026
·
2 min read
Immunology and inflammation
Sanofi Stumbles Again in Eczema—But Plans FDA Filing for OX40 Blocker Anyway
The mixed data from the Phase III COAST 2 trial follows an underwhelming data drop from COAST 1 in September that Leerink Partners said “fell well below expectations.”
January 23, 2026
·
2 min read
·
Tristan Manalac
Approvals
Vanda Ends 40-Year Motion Sickness Drug Drought With FDA Approval for Nereus
Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are dissatisfied with existing treatments.
January 2, 2026
·
3 min read
·
Nick Paul Taylor
Press Releases
Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025
February 4, 2026
·
26 min read
Press Releases
BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion
January 27, 2026
·
7 min read
Press Releases
Envoy Medical Announces the Grant of Its 40th U.S. Patent
December 2, 2025
·
1 min read
Press Releases
Pharma 4.0 Market Size Worth USD 81.20 Billion By 2034
December 2, 2025
·
1 min read
Press Releases
Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0
November 7, 2025
·
7 min read
Press Releases
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics
January 8, 2026
·
4 min read
1 of 17,379
Next
